Overview

Study to Evaluate Bioavailability of a Single 12 mg Dose of Perampanel for Three Intravenous Infusion Durations Relative to a Single 12 mg Perampanel Oral Tablet in Healthy Subjects

Status:
Completed
Trial end date:
2018-02-16
Target enrollment:
Participant gender:
Summary
This study will be conducted to evaluate the bioavailability of a single 12 milligram (mg) dose of perampanel intravenous infusions of different durations relative to a single 12 mg dose of perampanel oral tablet in healthy participants.
Phase:
Phase 1
Details
Lead Sponsor:
Eisai Inc.